<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00613860</url>
  </required_header>
  <id_info>
    <org_study_id>02/08</org_study_id>
    <nct_id>NCT00613860</nct_id>
  </id_info>
  <brief_title>Sequential Endoscopic Lung Volume Reduction</brief_title>
  <official_title>Sequential Endoscopic Lung Volume Reduction in Patients With Heterogeneous Lung Emphysema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Humboldt-Universität zu Berlin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with heterogenous emphysema benefits from endoscopic lung volume reduction. Until
      now the technique is limited to one lobe. In case of collateral ventilation patients show no
      improvement. Between upper and middle lobe exists the highest collateral flow. The trial
      examine the hypothesis, that sequential ELVR help especially those patients, which have no
      benefit after lobar exclusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with heterogenous emphysema undergo ELVR, target lobe is the upper lobe right. After
      6 weeks the middle lobe will be block too.

      Follow-up period 6 months Primary end points: FEV 1, 6-Minute walk test Secondary endpoints.
      Safety, Symptom scores Number of patients planned 30
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FEV 1 6 Minute walk test</measure>
    <time_frame>6 months after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety Symptom scores</measure>
    <time_frame>6 months after intervention</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Emphysema</condition>
  <condition>COPD</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zephyr endobronchial valve</intervention_name>
    <description>Endobronchial valve system to redirect the airflow within the bronchial system</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heterogenous emphysema

          -  FEV1 &lt; 45%

          -  RV &gt; 150%

          -  TLC &gt; 100%

          -  TLCO &lt; 40%

        Exclusion Criteria:

          -  Homogeneous emphysema

          -  Pregnancy

          -  PCO2 &gt; 50 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix JF Herth, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thoraxklinik, University of Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ralf Eberhardt, ND</last_name>
    <phone>+49-6221-396 8204</phone>
    <email>Ralf.Eberhardt@thoraxklinik-heidelberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jutta Kappes, MD</last_name>
    <phone>+49-6221-396-8705</phone>
    <email>Jutta.Kappes@thoraxklinik-heidelberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charite, University of Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Witt, MD, PhD</last_name>
      <phone>+49 (030) 450 565 022</phone>
      <email>pneumologie@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Bernd Schmitt, MD</last_name>
      <phone>+49 (030) 450 565 02</phone>
      <email>pneumologie@charite.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik, University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69190</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Felix JF Herth, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Center Nürnberg</name>
      <address>
        <city>Nürnberg</city>
        <zip>90340</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Ficker, MD, PHD</last_name>
      <phone>+49 (911) 398-2675</phone>
      <email>ficker@klinikum-nuernberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Manfred Wagner, MD</last_name>
      <phone>+49 (911) 398-0</phone>
      <email>Manfred.Wagner@klinikum-nuernberg.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Strange C, Herth FJ, Kovitz KL, McLennan G, Ernst A, Goldin J, Noppen M, Criner GJ, Sciurba FC; VENT Study Group. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med. 2007 Jul 3;7:10.</citation>
    <PMID>17711594</PMID>
  </reference>
  <reference>
    <citation>de Oliveira HG, Macedo-Neto AV, John AB, Jungblut S, Prolla JC, Menna-Barreto SS, Fortis EA. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest. 2006 Jul;130(1):190-9.</citation>
    <PMID>16840401</PMID>
  </reference>
  <reference>
    <citation>Venuta F, de Giacomo T, Rendina EA, Ciccone AM, Diso D, Perrone A, Parola D, Anile M, Coloni GF. Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema. Ann Thorac Surg. 2005 Feb;79(2):411-6; discussion 416-7.</citation>
    <PMID>15680805</PMID>
  </reference>
  <reference>
    <citation>Yim AP, Hwong TM, Lee TW, Li WW, Lam S, Yeung TK, Hui DS, Ko FW, Sihoe AD, Thung KH, Arifi AA. Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg. 2004 Jun;127(6):1564-73.</citation>
    <PMID>15173708</PMID>
  </reference>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2008</study_first_submitted>
  <study_first_submitted_qc>February 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2008</study_first_posted>
  <last_update_submitted>April 26, 2011</last_update_submitted>
  <last_update_submitted_qc>April 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Felix JF Herth, MD, Phd; FCCP</name_title>
    <organization>Thoraxklinik, University of Heidelberg</organization>
  </responsible_party>
  <keyword>Endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

